Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway.

Saved in:
Bibliographic Details
Title: Radiosensitization by enzalutamide for human prostate cancer is mediated through the DNA damage repair pathway.
Authors: Sekhar KR; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America., Wang J; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America., Freeman ML; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America., Kirschner AN; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Source: PloS one [PLoS One] 2019 Apr 01; Vol. 14 (4), pp. e0214670. Date of Electronic Publication: 2019 Apr 01 (Print Publication: 2019).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0214670